Original Source(s)
Related Content
Comparative evaluation of SBS and RASS for sedation assessment in mechanically ventilated children
May 25, 2026
New Label Expansion in Generalized Myasthenia Gravis
Phase 3 ADAPT SERON data supported efgartigimod use across antibody subtypes often underrepresented in trials.
May 11, 2026
-
2 min
FDA Monthly Preview: Key June Decisions to Watch
Several FDA decisions across multiple specialties are expected this month.
May 29, 2026
-
3 min